Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zinzani, P.
Right arrow Articles by Tura, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zinzani, P.
Right arrow Articles by Tura, S
Haematologica, Vol 81, Issue 2, 132-137
Copyright © 1996 by Ferrata Storti Foundation

Journal Article

Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients

PL Zinzani, F Gherlinzoni, G Piovaccari, G Frezza, M Bendandi, RM Ferretti, E Barbieri, M Fiacchini, L Babini, B Magnani, and S Tura

Institute of Hematology Seragnoli, University of Bologna, Italy.

BACKGROUND. During the last 20 years Hodgkin's disease (HD) has become one of the most curable neoplasms; in fact, more than 75-80% of patients are expected to achieve long-term relapse-free survival with appropriate therapy. However, overall survival has been affected by intercurrent or treatment-induced diseases such as the increased risk of cardiac toxicity in patients who received mediastinal irradiation. METHODS. The incidence of cardiac abnormalities after mediastinal radiotherapy was assessed in 102 consecutive HD patients who underwent this treatment from January 1970 to December 1980. Basal investigation procedures included electrocardiogram and echocardiography; myocardial perfusion scintigraphy with 201-thallium and coronary arteriography were performed in selected patients. RESULTS. Eleven patients (10.8%) presented cardiac abnormalities, which were asymptomatic in three cases. Eight cases of myocardial ischemia and 3 of constrictive pericarditis were observed. The incidence of late cardiotoxic effects was related to total mediastinal dose and to the irradiation technique. CONCLUSIONS. The increasing duration of follow-up shows that as mediastinal irradiation increases so does the risk of late cardiotoxic side effects. For this reason, a proper treatment strategy should reduce these risk factors through new combined modality protocols and routine evaluation of cardiologic follow-up.


This article has been cited by other articles:


Home page
 BloodHome page
E. C. Moser, E. M. Noordijk, F. E. van Leeuwen, S. le Cessie, J. W. Baars, J. Thomas, P. Carde, J. H. Meerwaldt, M. van Glabbeke, and H. C. Kluin-Nelemans
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma
Blood, April 1, 2006; 107(7): 2912 - 2919.
[Abstract] [Full Text] [PDF]

Home page
 Journal of the American Dental AssociationHome page
A. H. FRIEDLANDER, E. C. SUNG, and J. S. CHILD
Radiation-induced heart disease after Hodgkin's disease and breast cancer treatment: Dental implications
J Am Dent Assoc, December 1, 2003; 134(12): 1615 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
P Owens, G Morgan-Hughes, S Kelly, N Ring, and A J Marshall
Myeloma and a mass in the heart
J R Soc Med, June 1, 2003; 96(6): 288 - 289.
[Full Text] [PDF]

Home page
 JCOHome page
E. Duhmke, J. Franklin, M. Pfreundschuh, S. Sehlen, N. Willich, U. Ruhl, R.-P. Muller, P. Lukas, A. Atzinger, U. Paulus, et al.
Low-Dose Radiation Is Sufficient for the Noninvolved Extended-Field Treatment in Favorable Early-Stage Hodgkin's Disease: Long-Term Results of a Randomized Trial of Radiotherapy Alone
J. Clin. Oncol., June 1, 2001; 19(11): 2905 - 2914.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 1996 by the Ferrata Storti Foundation.